# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
https://www.beyondmeat.com/en-US/whats-new/a-recent-article-published-in-the-lancet-diabetes-and-endocrinology-journal-
https://www.cnbc.com/2024/09/04/beyond-meat-to-launch-new-steak-alternative-as-it-focuses-on-health.html
Mizuho analyst John Baumgartner maintains Beyond Meat (NASDAQ:BYND) with a Underperform and lowers the price target from $6 ...
BMO Capital analyst Andrew Strelzik maintains Beyond Meat (NASDAQ:BYND) with a Market Perform and lowers the price target fr...
Beyond Meat reported second-quarter revenue of $93.2 million, beating the consensus estimate of $87.81 million, according to Be...
2024 OutlookBased on management's best assessment of the environment today, the Company is updating its outlook for the ful...